Vicore Pharma Holding AB Financial Overview
Vicore Pharma Holding AB's market cap is currently €257.74M. The company's EPS TTM is €-0.044310683999999996; its P/E ratio is -5.34; Vicore Pharma Holding AB is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
